Venkat Ramanan
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Venkat Ramanan is currently Chief Financial Officer at Immatics NV since 2025.
Former positions include Chief Financial Officer at Turnstone Biologics Corp.
from 2022 to 2024, Chief Financial Officer at Anthos Therapeutics, Inc., and Senior Vice President-Finance at Seagen, Inc. Education includes a doctorate from The Ohio State University.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMATICS N.V. -.--% | 18-03-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMATICS N.V. | Financieel Directeur/CFO | 01-10-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Financieel Directeur/CFO | 25-10-2024 |
| SEAGEN INC. | Financieel Directeur/CFO | - |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Financieel Directeur/CFO | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Seagen, Inc.
Seagen, Inc. Pharmaceuticals: MajorHealth Technology Develops monoclonal antibody-based therapeutic products for treatment of cancer and immunologic diseases | Health Technology |
The Ohio State University
The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Turnstone Biologics Corp.
Turnstone Biologics Corp. BiotechnologyHealth Technology Develops and sells medicines to treat and cure solid tumors | Health Technology |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutic options for the treatment of cardiovascular metabolic diseases | Health Technology |
Immatics NV
Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau